Sep 29, 2014 6:00am EDT Tonix Pharmaceuticals Reports Top Line Results From Phase 2b BESTFIT Trial of TNX-102 SL in Patients With Fibromyalgia
Sep 3, 2014 8:40am EDT Tonix Pharmaceuticals to Present at the Rodman & Renshaw Global Investment Conference
Jun 26, 2014 8:30am EDT Tonix Pharmaceuticals Appoints Ronald R. Notvest, Ph.D. as Senior Vice President of Commercial Planning and Development
Jun 10, 2014 8:30am EDT Tonix Pharmaceuticals Receives IND Clearance From U.S. Food and Drug Administration for TNX-102 SL in Post-Traumatic Stress Disorder
